$76M sweet spot round size
Most of their 44 investments are in rounds between $57M and $115M
2018
Star Therapeutics raised $90M on September 5, 2023
Investors: Qatar Investment Authority, Westlake Village BioPartners®, Sofinnova Ventures, Russia technology fund, Redmile Group, New Leaf Venture Partners, NYBC Ventures, OrbiMed Advisors, RA Capital Management, L.P. and Soleus Capital Management, L.P.
Beta Bionics raised $100M on August 30, 2023
Investors: Sands Capital Management, Farallon Capital Management, Pura Vida Investments, Perceptive Advisors, Marshall Wace, RTW Investments, LP, Eventide Asset Management, LifeSci Venture Partners, Omega Funds and Soleus Capital Management, L.P.
COMPASS Pathways raised $125M on August 16, 2023
Investors: Vivo Capital, Laurion Capital Management LP, Partner Fund Management, RA Capital Management, L.P., Surveyor Capital, Logos Global Management, LP, TCG X, Armistice Capital LLC and Soleus Capital Management, L.P.
Septerna raised $150M on July 11, 2023
Investors: Goldman Sachs Asset Management, The Invus Group, Third Rock Ventures, Woodline Partners LP, RA Capital Management, L.P., Samsara BioCapital, Logos Global Management, LP, Vertex Ventures HC and Soleus Capital Management, L.P.
InspireMD raised $114M on May 15, 2023
Investors: Velan Capital, LifeSci Capital, LLC, OrbiMed Advisors, Marshall Wace and Soleus Capital Management, L.P.
BioAtla, Inc. raised $65M on November 4, 2022
Investors: Adage Capital Management, Acuta Capital, Vivo Capital and Soleus Capital Management, L.P.
RayzeBio raised $160M on September 13, 2022
Investors: Laurion Capital Management LP, Sands Capital Management, Viking Global Investors, Sofinnova Ventures, Russia technology fund, Wellington Management and Soleus Capital Management, L.P.
Undisclosed raised $100M on May 16, 2022
Investors: RA Capital Management, L.P., Commodore Capital, LP and Soleus Capital Management, L.P.
LimFlow SA raised $39M on April 5, 2022
Investors: Longitude Capital, Sofinnova Partners and Soleus Capital Management, L.P.
Beta Bionics raised $57M on February 17, 2022
Investors: Pura Vida Investments, Novo Nordisk Ltd, LifeSci Venture Partners, Eventide Asset Management, RTW Investments, LP, Farallon Capital Management, Perceptive Advisors and Soleus Capital Management, L.P.